| 摘要 |
Compounds represented by the general formula (I): R<1>-A-R<2> or pharmacologically acceptable salts thereof wherein R<1> represents (un)substituted alkanoyl, (un)substituted aroyl, (un)substituted heteroarylcarbonyl, (un)substituted alkoxycarbonyl, (un)substituted aryloxycarbonyl, (un)substituted heteroaryloxycarbonyl, or hydrogen; R<2> represents hydroxy, (un)substituted alkoxy or (un)substituted amino; and A represents a partial peptide sequence comprising at least 12 consecutive amino acid residues in the sequence of a dimer forming or DNA binding region of each member of E2F family. |
